InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the full record of transactions filed by Skolnick Phil, Directeur Scientifique. Insider active across 1 companies, notably Opiant Pharmaceuticals, INC.. Cumulatively, 7 reports have been published. Total volume traded: €91k. The latest transaction was filed on 27 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
02,000 shares0
Common Stock
SEC:0001385508-22-000101:0·
€35,3591,518 shares@ €23.293438.7% of flow
Common Stock
SEC:0001385508-22-000026:0·
€35,3591,518 shares@ €23.293477.4% of flow
Common Stock
SEC:0001385508-22-000026·
€10,339385 shares@ €26.854122.6% of flow
Common Stock
SEC:0001385508-22-000021·
€10,339385 shares@ €26.854111.3% of flow
Common Stock
SEC:0001385508-22-000021:0·
012,000 shares0
Common Stock
SEC:0001385508-22-000013·
012,000 shares0
Common Stock
SEC:0001385508-22-000013:0·
7 of 7 declarations
About Skolnick Phil
Phil Skolnick is Chief Scientific Officer at Opiant Pharmaceuticals, Inc. He is responsible for the scientific direction of the company, overseeing research and development of new products. His expertise is essential for innovation and the success of Opiant Pharmaceuticals.
